Abiopharma

News list

Sullivan Christopher Ryan 🔴 sold 155 shares of Avalo Therapeutics, Inc. (AVTX) at $4.10 Transaction Date: Dec 10, 2025 | Filing ID: 000409

Full text

News bot Dec. 12, 2025, 9:22 p.m.
🔍 Sullivan Christopher Ryan (Executive)

Company: Avalo Therapeutics, Inc. (AVTX)

Report Date: 2025-12-10
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 155
Detailed Transactions and Holdings:
- Sold 155 shares of Common Stock at $4.1 per share (Direct)
  Date: 2025-12-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 17,338.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Includes 417 additional shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.